Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,220.62 -415.60 (-2.12%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
69,740.12 +1,575.80 (+2.31%) CMC Crypto 200
1,523.11 +34.57 (+2.32%)
ABEO May 2024 2.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:44PM EDT. Market open.
| Previous close | 2.0000 |
| Open | 2.0000 |
| Bid | 1.0000 |
| Ask | 5.0000 |
| Strike | 2.50 |
| Expiry date | 2024-05-17 |
| Day's range | 1.2500 - 2.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
- GuruFocus.com
Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
Explore key financial outcomes and strategic updates from Abeona Therapeutics' first quarter earnings call.
- Thomson Reuters StreetEvents
Q1 2024 Abeona Therapeutics Inc Earnings Call
Q1 2024 Abeona Therapeutics Inc Earnings Call
GlobeNewswireAbeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, extending expected cash runway into 2026 CLEVELAND, May 15, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the first quarter of 2024 and recent corporate progress. “We are grateful to our existing as well as new investors who have demonstrated their support through the recent financing, which has extended our cash runway into 2026, well beyon
© 2024 Yahoo. All rights reserved.